Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New App-Supported therapy for teen PTSD tested in sweden

NCT ID NCT07407946

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests a new way to deliver trauma-focused therapy to teens with PTSD. It combines therapist-led video sessions with a mobile app for self-paced exercises. Researchers want to see if this blended approach is feasible and acceptable compared to standard therapy. About 40 teens in northern Sweden will take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Blended Trauma-Focused Cognitive Behavioral Therapy with Compassion (bTF-CBT-C)
What this could lead to
If successful, this could point toward a more accessible, app-supported therapy option for teens with PTSD.
What could go wrong
This is a small pilot study with only 40 participants, so results may not apply widely. The app-based format may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adolescents aged 12-17 years. * Meet DSM-5 criteria for post-traumatic stress disorder (PTSD) confirmed by diagnostic interview (MINI-KID). * Score ≥25 on the Child and Adolescent Trauma Screen (CATS-2) at baseline. * Receiving care within routine child and adolescent psychiatric services in participating regions. * Have a non-offending caregiver willing and able to participate in caregiver components of treatment. * Able to communicate in Swedish sufficiently to engage in treatment and assessments. * Provide informed assent/consent, with caregiver consent according to age and regulations. Exclusion Criteria: * Acute suicidality or risk requiring inpatient care. * Active psychotic disorder or severe dissociative symptoms that interfere with participation. * Autism spectrum disorder, severe eating disorder, or obsessive-compulsive disorder requiring primary specialized treatment. * Ongoing trauma exposure or unstable living conditions that would prevent safe participation. * Cognitive impairment or medical condition that precludes participation in psychotherapy or digital components. * Substance use disorder requiring treatment, or regular use of benzodiazepines (\> once per week). * Concurrent trauma-focused psychotherapy or recent initiation/discontinuation of psychotropic medication (within the past 6 weeks), or planned medication changes during the study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post traumatic stress disorder PTSD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Umeå University, Clinical Science, Child- and Adolescent Psychiatry

    RECRUITING

    Umeå, 901 87, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.